Meet The CEOs – Virtual Event

Connect with leading ASX listed Companies

Meet The CEOs - Small Cap Webcast

Wednesday 10th June 12pm-1pm AEST

Get a seat at the table and hear directly from CEOs and business leaders.
This week join 3 CEOs of exciting ASX listed businesses, they will be giving valuable insight to their industries and companies future prospects.

Event Details:
Date: Wednesday 10 June 2020
Event agenda: Online, 3 x 15-minute presentations
Time: 12pm – 1pm AEST

This week we will be joined by:

  • Dennis Karp – Manuka Resources (Initial Public Offering*)
  • Sol Lukatsky – Spirit Telecom (ASX – ST1)
  • Matt Liddelow – Neuroscientific Biopharmaceuticals (ASX – NSB)

This is a live and interactive session, you simply need an internet connection to participate. Don’t miss out, spots are limited – This is a FREE event.

Attend this session

By clicking submit, I agree to the terms of the Reach Markets Financial Services Guide that includes the Privacy Statement.

Featured Speakers

Dennis Karp

Manuka Resources (Impending IPO*)

Manuka is Australia’s newest gold & silver producer and commenced production in April 2020 and is expected to mine and process over 30,000 ounces of gold in its first 12 months. Manuka owns 100% of two, fully permitted Gold and Silver assets located in the Cobar Basin of NSW. Manuka Resources purchased the Wonawinta project in late 2016 and acquired Mt Boppy Resources P/L the holder of the high-grade historic Mt Boppy gold project, in mid-2019. The Company expects to list on the Australian Securities Exchange (ASX) on the 14th of July 2020.

Sol Lukatsky

Spirit Telecom (ASX-ST1)

Spirit Telecom (ASX:SP1) has been built on the simple premise that Australian businesses deserve better, faster and more reliable internet – and it’s grown rapidly to become a leading provider of high speed internet and IT & managed services to SMBs and essential industries such as hospitals, schools, aged-care and government. Spirit Telecom is a nimble company that is achieving high-growth due to its compelling service offering and delivery for clients, along with its smart, disciplined acquisition strategy. Now firmly established as a challenger brand with the infrastructure and expertise to take on the industry giants, Spirit Telecom is accelerating its growth plans, via its digital platform Spirit X and through acquisitions.

Matt Liddelow

Neuroscientific Biopharmaceuticals (ASX – NSB)

NeuroScienfitic Biopharmaceuticals Ltd (ASX: NSB) is a drug development company focused on developing novel peptide-based pharmaceutical drugs for the treatment of neurodegenerative conditions with high unmet medical need. NSB’s lead drug candidate, called EmtinB, is currently being developed as a treatment for neurodegenerative dementia and Alzheimer’s disease, and degenerative conditions of the optic nerve. EmtinB is in the advanced preclinicalphase of development with clinical development set to start by the end of 2020.

*The IPO of securities in Manuka Resources Limited will be made in, or accompanied by, a copy of the prospectus available at Automic Registry Services.  You should consider the prospectus in deciding whether to acquire the securities and anyone acquiring the securities will need to complete the application form that will be in or will accompany the prospectus.  Reach Markets are the advisors assisting with the management of the offer and may receive fees if an application is made by investors.